Clarivate PLC
CLVT4.307USD
-0.002-0.06%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
2.94BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Clarivate PLC Unternehmen
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.
Unternehmensinformationen
Unternehmens-codeCLVT
Name des UnternehmensClarivate PLC
IPO-datumOct 29, 2018
Gegründet am2019
CEOMr. Matitiahu Shem (Matti) Tov
Anzahl der mitarbeiter12000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 29
Addresse70 St. Mary Axe
StadtLONDON
BörseNYSE Consolidated
LandUnited Kingdom
PostleitzahlEC3A 8BE
Telefon442074334000
Websitehttps://clarivate.com/
Unternehmens-codeCLVT
IPO-datumOct 29, 2018
Gegründet am2019
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
451.59K
+93.78%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
82.02K
+245.46%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
71.83K
+46.67%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
57.73K
--
Mr. Michael J. Angelakis
Mr. Michael J. Angelakis
Independent Director
Independent Director
56.09K
--
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Ms. Suzanne Heywood
Ms. Suzanne Heywood
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
451.59K
+93.78%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
82.02K
+245.46%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
71.83K
+46.67%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
57.73K
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Subscription revenues
1.63B
63.63%
Transactional revenues
500.10M
19.56%
Re-occurring revenues
429.80M
16.81%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
1.38B
54.03%
Europe/ Middle East /Africa
667.80M
26.12%
Asia Pacific
507.50M
19.85%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Subscription revenues
1.63B
63.63%
Transactional revenues
500.10M
19.56%
Re-occurring revenues
429.80M
16.81%
Aktionäre
Update-Zeit: Sun, Feb 23
Update-Zeit: Sun, Feb 23
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Leonard Green & Partners, L.P.
17.08%
Clarkston Capital Partners, LLC
10.35%
Giovanni Agnelli B V
9.85%
Impactive Capital LP
6.30%
Onex Corporation
6.14%
Other
50.28%
Aktionärsstatistik
Aktionäre
Anteil
Leonard Green & Partners, L.P.
17.08%
Clarkston Capital Partners, LLC
10.35%
Giovanni Agnelli B V
9.85%
Impactive Capital LP
6.30%
Onex Corporation
6.14%
Other
50.28%
Art
Aktionäre
Anteil
Investment Advisor
30.25%
Private Equity
30.20%
Investment Advisor/Hedge Fund
18.94%
Hedge Fund
11.75%
Holding Company
9.77%
Corporation
5.53%
Individual Investor
1.00%
Research Firm
0.99%
Bank and Trust
0.94%
Institutionelle Beteiligung
Update-Zeit: Sat, Feb 22
Update-Zeit: Sat, Feb 22
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
674
765.26M
112.02%
-141.15M
2024Q4
712
766.77M
110.84%
-166.20M
2024Q3
726
765.53M
108.25%
-158.23M
2024Q2
741
760.08M
105.78%
-120.39M
2024Q1
752
730.14M
108.67%
-137.39M
2023Q4
783
725.50M
108.90%
-179.38M
2023Q3
791
741.16M
111.25%
-79.71M
2023Q2
796
712.25M
105.35%
-100.17M
2023Q1
777
702.68M
104.01%
-43.46M
2022Q4
788
663.31M
98.18%
-69.01M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Leonard Green & Partners, L.P.
116.67M
16.93%
--
--
Dec 31, 2024
Clarkston Capital Partners, LLC
70.73M
10.27%
-1.48M
-2.04%
Dec 31, 2024
Giovanni Agnelli B V
67.29M
9.77%
--
--
Dec 31, 2024
Impactive Capital LP
43.03M
6.25%
+3.40M
+8.58%
Dec 31, 2024
Onex Corporation
42.86M
6.22%
--
--
Mar 15, 2024
Selige Co-Investor Pooling SCSp
38.09M
5.53%
--
--
Mar 15, 2024
The Baupost Group, L.L.C.
36.28M
5.27%
-2.65M
-6.81%
Dec 31, 2024
T. Rowe Price Associates, Inc.
27.41M
3.98%
+9.67M
+54.48%
Dec 31, 2024
Partners Group AG
25.58M
3.71%
--
--
Dec 31, 2024
Cambridge Information Group, Inc.
23.61M
3.43%
--
--
Mar 15, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
AGF US Market Neutral Anti-Beta Fund
0.48%
WisdomTree US MidCap Fund
0.17%
John Hancock Multifactor Small Cap ETF
0.17%
Avantis US Small Cap Value ETF
0.15%
JPMorgan US Value Factor ETF
0.15%
T Rowe Price Small-Mid Cap ETF
0.14%
Nuveen ESG Small-Cap ETF
0.14%
Strive Small-Cap ETF
0.1%
BNY Mellon US Small Cap Core Equity ETF
0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
0.07%
Mehr Anzeigen
AGF US Market Neutral Anti-Beta Fund
Anteil0.48%
WisdomTree US MidCap Fund
Anteil0.17%
John Hancock Multifactor Small Cap ETF
Anteil0.17%
Avantis US Small Cap Value ETF
Anteil0.15%
JPMorgan US Value Factor ETF
Anteil0.15%
T Rowe Price Small-Mid Cap ETF
Anteil0.14%
Nuveen ESG Small-Cap ETF
Anteil0.14%
Strive Small-Cap ETF
Anteil0.1%
BNY Mellon US Small Cap Core Equity ETF
Anteil0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
Anteil0.07%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten